Improvement in the results of tests of ventilatory function in response to a bronchodilator drug, given by inhalation or by injection, is now widely used to indicate the presence of reversible " bronchospasm" (Rossier, 1949; Gilson and Hugh-Jones, 1955; Kennedy and Thursby-Pelham, 1956 time interval, and is designated F.E.V. 0. 75, F.E.V.1.0, or F.E.V.2.0. For present purposes the highest ofeach group of three recordings was selected. The total volume of air expired (the forced vital capacity) was also noted. The tests were repeated before and after isoprenaline every day while the patient was in hospital, and thereafter weekly.
Improvement in the results of tests of ventilatory function in response to a bronchodilator drug, given by inhalation or by injection, is now widely used to indicate the presence of reversible " bronchospasm" (Rossier, 1949; Gilson and Hugh-Jones, 1955; Kennedy and Thursby-Pelham, 1956 ). Frequent repetition of some of these tests in a small series of patients has revealed an interesting relationship between the initial values for the tests and the changes observed after the inhalation ofisoprenaline.
METHOD
Six patients admitted to King Edward VII Sanatorium because of a severe exacerbation of " intrinsic " asthma were selected for study. It was hoped that frequent observations of a small group might prove more rewarding than isolated tests of a larger series. The diagnosis was based upon the history of recurrent attacks of severe wheezing, sometimes precipitated by a " cold," but otherwise without obvious external cause, with intervening periods of relative freedom. Except in one patient who had been asthmatic since childhood, the symptoms began during middle life. None of the patients was regarded as having predominantly chronic bronchitis. The ages of the patients ranged from 39 to 60 years; four were women.
The spirometer was of the type described by Bernstein, D'Silva, and Mendel (1952) (Fig. 1) , with a well-defined maximum value for the increase after isoprenaline, corresponding to a value between the lowest and highest recorded for the pre-inhalation forced expiratory volume. In all cases this peak was observed after five to seven days of treatment. This relationship is not merely a function of improvement in response with the passage of time, as can be shown by re-plotting the data with duration of hospital stay as abscissa.
Three curves for the FRE.V.1.o are reproduced ( Fig. 1) . Patient A was studied through two complete cycles of exacerbation and remission; the results were so similar that they are here shown as a single curve.
When the results for the total amount of air expired (forced vital capacity) were similarly plotted, the shape of the curves was found to be the same. However, the points showed a much greater scatter, related in some instances to marked differences in the time taken over expiration before The small quantities produced after each bout of coughing rapidly formed a homogeneous mass in the sputum mug. It is also notable that even when this patient was remarkably free of respiratory symptoms, during prednisone therapy, he had a vital capacity of only 2,400 ml. (about two-thirds his predicted value), and he could expire only 50% of this within the first second (normal, 75-85%).
It is possible that the comparatively unsatisfactory curve obtained in this patient was related to the excessive production of a peculiarly viscid mucus in conjunction with permanent structural changes in the lungs.
From the curves shown in Fig. 1 , it can be seen that, to the left of the peak, the response increases with increase in the pre-inhalation level of the F.E.V. The absolute response to isoprenaline inhalation is relatively poor when the initial forced expiratory values are low. The reason for this is not certain. The shape of the curves plotted in Fig. 1 strongly suggests that at least two factors are involved in the bronchodilator effect of isoprenaline; these may be related to two or more of the recognized factors in asthmatic wheezing, namely, bronchial spasm, mucosal oedema or inflammation, and mucus plugging. The lack of progressive improvement when the time of isoprenaline administration is prolonged suggests that the relatively small response is not due simply to ineffective ventilation, or at least to ineffective ventilation of those parts of the lung capable of any ventilation at all. This observation is supported clinically by auscultation of the chest in some patients during the inhalation of isoprenaline. The characteristic high-pitched rhonchi present at rest disappear after two or three breaths of isoprenaline mist. At this stage highpitched rhonchi can still be elicited by forced expiration, and these are unaltered, as far as can be ascertained, by further inhalation of isoprenaline.
The implications of this relationship between response to isoprenaline and the initial level of forced expiratory volume and vital capacity are of interest. Extrapolation of the right-hand limb of the curve relating response to initial level offers an approximate estimate of the maximum value which a particular patient may be expected to attain. Comparison of this figure with a value predicted from the age, sex, and stature of the patient may then provide an estimate of the lung damage present which is irreversible by the therapy employed. Thus, from the " isoprenaline response curve" A in Fig. 1 it can be seen that the highest likely F.E.V.1 , is about 3,000 ml. From the similar curve constructed for forced vital capacity in this patient, the maximum vital capacity was found to be 4,500 ml., which was the same as the predicted normal for this patient. As he can expire approximately 66% (normal 75-85%) of this within the first second, he may be regarded as having relatively little irreversible lung damage. On the other hand, one of the patients could expire no more than 50% of a rather low vital capacity, even at her best, and in the virtual absence of demonstrable reversible bronzhial constriction.
Construction of an " isoprenaline response curve" of the type described may prove helpful in controlling cortisone or prednisone dosage, particularly when it is desired to keep this to a minimum. None of the patients was conscious of respiratory disability when the forced expiratory volume was at the level associated with the maximum isoprenaline response. The maintenance dosage selected may therefore be kept to that necessary to maintain this level, rather than that required to achieve a more " normal " state.
Finally, it is possible that the pattern of response to isoprenaline depicted in the graphs may be found to apply to other bronchodilator drugs. If this should prove to be the case, care must be taken in evaluating the results of ventilatory function tests when they are used to compare the effects of one drug with another. In prolonged clinical trials there may be not only the well-recognized hazard of spontaneous variation in the initial level of fast expiratory capacity, but also a risk of concomitant variation in the response produced by the drugs under trial. It may be difficult to make allowance for this effect. 
